These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18830004)

  • 1. Vascular changes and black hole phenomenon after coronary brachytherapy: a pathologically distinct entity.
    Koshy SK; Kleiman NS; George LK; Misra V; Hillegass WB; Brott BC
    J Invasive Cardiol; 2008 Oct; 20(10):560-2. PubMed ID: 18830004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.
    Costa MA; Sabate M; Angiolillo DJ; Jimenez-Quevedo P; Teirstein P; Carter A; Leon MB; Moses J; Zenni M; Yakubov S; Guzman LA; Gilmore P; Macaya C; Bass TA
    Am J Cardiol; 2006 Jan; 97(2):203-6. PubMed ID: 16442364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of shear stress with in-stent restenosis: bare metal stenting and the effect of brachytherapy.
    Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Fotiadis DI; Michalis LK
    Int J Cardiol; 2009 May; 134(1):25-32. PubMed ID: 18556077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and determinants of black holes in sirolimus-eluting stent restenosis.
    Costa Jde R; Mintz GS; Carlier SG; Fujii K; Sano K; Kimura M; Tanaka K; Lui J; Moses JW; Leon MB
    J Invasive Cardiol; 2006 Aug; 18(8):348-52. PubMed ID: 16877780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The black hole: echolucent tissue observed following intracoronary radiation.
    Kay IP; Ligthart JM; Virmani R; van Beusekom HM; Kozuma K; Carter AJ; Sianos G; van der Giessen WJ; Wardeh AJ; de Feyter PJ; Serruys PW
    Int J Cardiovasc Intervent; 2003; 5(3):137-42. PubMed ID: 12959730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents.
    Chieffo A; Foglieni C; Nodari RL; Briguori C; Sangiorgi G; Latib A; Montorfano M; Airoldi F; Michev I; Carlino M; Colombo A; Maseri A
    Am J Cardiol; 2009 Dec; 104(12):1660-7. PubMed ID: 19962471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
    Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
    JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
    Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
    Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-stent restenosis.
    Kim MS; Dean LS
    Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
    Sheppard R; Eisenberg MJ; Donath D; Meerkin D
    Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32P brachytherapy in the treatment of complex Cypher in-stent restenosis.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Marrozzini C; Palmerini T; Taglieri N; Branzi A
    J Interv Cardiol; 2005 Jun; 18(3):205-11. PubMed ID: 15966927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent-based delivery of antisense oligodeoxynucleotides targeted to the PDGF A-chain decreases in-stent restenosis of the coronary artery.
    Li Y; Fukuda N; Kunimoto S; Yokoyama S; Hagikura K; Kawano T; Takayama T; Honye J; Kobayashi N; Mugishima H; Saito S; Serie K
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):184-90. PubMed ID: 17086098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation.
    Kay IP; Wardeh AJ; Kozuma K; Sianos G; Regar E; Knook M; van der Giessen WJ; Thury A; Ligthart JM; Coen VM; Levendag PC; Serruys PW
    Eur Heart J; 2001 Aug; 22(15):1311-7. PubMed ID: 11465963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-based 32P beta-radiation after stent implantation in porcine coronary arteries: role of source-centering and geographical miss.
    Maeng M; Busk M; Tanderup K; Mertz H; Andersen HR; Thuesen L
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):247-57. PubMed ID: 14517934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.